# Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study

> **NCT02362880** · NA · TERMINATED · sponsor: **Judit Pich Martínez** · enrollment: 32 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **RADIATION:** Florbetaben

## Key facts

- **NCT ID:** NCT02362880
- **Lead sponsor:** Judit Pich Martínez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** On 15 January 2019, the sponsor decided to stop the study prematurely due to lack of patient recruitment because of supply problems with 18 F-Florbetaben.
- **Last updated:** 2021-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02362880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02362880, "Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease 18F-Florbetaben Positron Emission Tomography Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02362880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*